We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. OK, I agree | Cookies Policy

You are here

Magazine

8

Gelsectan® Launched In Spain

We are pleased to announce the launch of our new IBS product Gelsectan® in its first market, Spain. The product is distributed by Norgine, as part of an agreement signed last March: http://noventure.com/corporate-press-release-norgine-and-noventure-enter-agreement-commercialize-gelsectanr-spain

Read more

Noventure welcomes new partners to expand the presence of its products in new territories.

We are pleased to announce that we are expanding the international coverage of our products thanks to the recent signature of agreements with both new and loyal partners. These new partnerships further enable us to spread our global footprint. Soon you will be able to find our products in the following territories:  Ukraine - Utipro® Plus (PHARM. FABRIK MONTAVIT GmbH)  Lebanon – Aprotecol®, Gelsectan® and Xilaplus® (SPEPHAL S.A.L.)  Romania and Greece – Gelsectan® (GALENICA, S.A.)  Israel - Gelsectan®, Aprotecol® and Tasectan® Duo (LAPIDOT MEDICAL).  South Africa - Aprotecol®, Utipro® Plus (CAMOX PHARMACEUTICALS Pty Ltd.)  Hungary – Tasectan® (ELVAPHARMA s.r.o.) Extending our collaboration with these valuable partners helps us to fulfill the mission to bring our innovative solutions to patients around the world. For further information about our products click here: http://noventure.com/products

Read more

Let's meet in..

2018, Aug 29

FNM 2018

FNM-2018-Amsterdam
Read more

2018, Oct 09

CPHI

Read more

2018, Oct 24

UEG Week 2018

Read more

2018, Nov 26

EuroPLX 68

Read more

2018, Nov 29

PharmaVenue November 2018

Read more